Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Wisee who wrote (505)	4/29/1998 11:38:00 PM
From: Paul S.	Read Replies (1) \| Respond to of 1185

Wisee, Neurex has a thread on SI, it makes for very interesting reading. This is the direction that Nortran is heading. It is only a matter of time before NRT is in phase III trials , that is when the real reward will come for shareholders with forward thinking. Unlike todays trading that I attribute to month end sellers and profit takers. Lets face it there has been a lot of speculation about licensing agreements, rumor has it that it is a big one, but what happened in the market today is people trying to capitalize on this news with a quick flip of the stock. That strategy is fine if you are able to hold your stock through month end. Actually what transpired today is a combination of profit taking and month end selling but however you look at it NRT needed this. Now we have a stock that has been flushed clean so we should see it move upwards again shortly. I have been told that there is a big directors meeting at NRT tomorrow, I wonder what this is for? Possibly the final approval? Today I received my Notice of AGM. For anyone who is interested it will be held in the Salon Renoir of the Sutton Place Hotel, 845 Burrard Street Van. BC on Thursday May 14 at 10:00am.